f8k021413_chinajojo.htm
 UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 
 
Date of report (Date of earliest event reported): February 15, 2013 (February 14, 2013)
 
CHINA JO-JO DRUGSTORES, INC.
(Exact name of registrant as specified in its charter)
 
Nevada
  
001-34711
  
98-0557852
(State or other jurisdiction of incorporation)
  
(Commission File No.)
  
(IRS Employer Identification No.)
 
Room 507-513, 5th Floor, A Building, Meidu Plaza
Gongshu District, Hangzhou, Zhejiang Province
People’s Republic of China
    
(Address of principal executive offices)
  
(Zip Code)
 
Registrant’s telephone number, including area code +86 (571) 88077078
 
N/A
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
 
 
 
Item 2.02. Results of Operations and Financial Condition.
 
On February 14, 2013, the registrant announced its audited results of operations for the three and nine months ended December 31, 2012.  A copy of the press release is annexed as Exhibit 99.1 hereto.
 
In accordance with General Instruction B.2 of Form 8-K, the information in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any of the registrant’s filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date hereof and regardless of any general incorporation language in such filings, except to the extent expressly set forth by specific reference in such a filing.
 
Item 9.01.   Financial Statement and Exhibits.

(d) EXHIBITS

Exhibit Number
  
Description
99.1
  
Press release dated February 14, 2013

 
 
 
 


SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

   
CHINA JO-JO DRUGSTORES, INC.
Date:
February 15, 2012
(Registrant)
       
   
By:
/s/ Ming Zhao
     
Ming Zhao
     
Chief Financial Officer